| scholarly article | Q13442814 |
| P50 | author | Shigeru Kohno | Q104013331 |
| P2093 | author name string | Akira Furusu | |
| Yuka Nakazawa | |||
| Masanobu Miyazaki | |||
| Takehiko Koji | |||
| Tomoya Nishino | |||
| Yoko Obata | |||
| Katsushige Abe | |||
| Masayuki Nakazawa | |||
| Misaki Hirose | |||
| P2860 | cites work | Vitamin D. | Q27919675 |
| A vitamin D analog ameliorates glomerular injury on rat glomerulonephritis | Q28364355 | ||
| Mechanisms of gene regulation by vitamin D(3) receptor: a network of coactivator interactions. | Q33892757 | ||
| TGF-beta signaling in renal disease | Q34869314 | ||
| Dissection of key events in tubular epithelial to myofibroblast transition and its implications in renal interstitial fibrosis | Q35746891 | ||
| Vitamin D signaling is modulated on multiple levels in health and disease. | Q36365856 | ||
| TGF-β signaling in fibrosis | Q37899212 | ||
| Expression of nuclear factor-kappaB in Helicobacter pylori-infected gastric mucosa detected with southwestern histochemistry | Q38313274 | ||
| Antisense oligonucleotides against collagen-binding stress protein HSP47 suppress peritoneal fibrosis in rats | Q38351568 | ||
| 1,25-dihydroxyvitamin D inhibits renal interstitial myofibroblast activation by inducing hepatocyte growth factor expression | Q40373228 | ||
| Recent advances in molecular histochemical techniques: in situ hybridization and southwestern histochemistry | Q41022098 | ||
| The nuclear vitamin D receptor: biological and molecular regulatory properties revealed. | Q41731155 | ||
| Increased NF-kappaB activity in fibroblasts lacking the vitamin D receptor | Q42491472 | ||
| 1,25-Dihydroxyvitamin D3 targeting of NF-kappaB suppresses high glucose-induced MCP-1 expression in mesangial cells | Q42512729 | ||
| Effect of 1,25(OH)(2)D(3) on rat peritoneal mesothelial cells treated with high glucose plus lipopolysaccharide | Q42729052 | ||
| Expression of the vitamin d receptor is increased in the hypertrophic heart | Q43118666 | ||
| A comparison between 1,25-dihydroxy-22-oxavitamin D(3) and 1,25-dihydroxyvitamin D(3) regarding suppression of parathyroid hormone secretion and calcaemic action. | Q44184100 | ||
| Inhibition of nuclear factor-kappaB activation by pyrrolidine dithiocarbamate prevents chronic FK506 nephropathy | Q44242805 | ||
| Integration of the NfkappaB p65 subunit into the vitamin D receptor transcriptional complex: identification of p65 domains that inhibit 1,25-dihydroxyvitamin D3-stimulated transcription | Q44947585 | ||
| TNP-470, an angiogenesis inhibitor, suppresses the progression of peritoneal fibrosis in mouse experimental model | Q45085906 | ||
| Podocyte injury is suppressed by 1,25-dihydroxyvitamin D via modulation of transforming growth factor-beta 1/bone morphogenetic protein-7 signalling in puromycin aminonucleoside nephropathy rats. | Q45931396 | ||
| Vitamin D3 regulation of transforming growth factor-beta system in epithelial and fibroblastic cells--relationships to plasminogen activation | Q47971675 | ||
| Sclerosing peritonitis in continuous ambulatory peritoneal dialysis patients: one center's experience and review of the literature. | Q50632964 | ||
| Transient overexpression of TGF-{beta}1 induces epithelial mesenchymal transition in the rodent peritoneum. | Q52561638 | ||
| Localization of cyclic adenosine 3',5'-monophosphate-responsive element (CRE)-binding proteins by southwestern histochemistry | Q64389684 | ||
| Sclerotic thickening of the peritoneal membrane in maintenance peritoneal dialysis patients | Q71288700 | ||
| Up-regulation of monocyte chemoattractant protein-1 in tubulointerstitial lesions of human diabetic nephropathy | Q73024328 | ||
| Differential time course of induction of 1alpha,25-dihydroxyvitamin D3-24-hydroxylase mRNA expression in rats by 1alpha,25-dihydroxyvitamin D3 and its analogs | Q74115675 | ||
| Convergence of transforming growth factor-beta and vitamin D signaling pathways on SMAD transcriptional coactivators | Q74485020 | ||
| Mechanism of vitamin D action and its regulation | Q77530591 | ||
| Morphologic changes in the peritoneal membrane of patients with renal disease | Q77531583 | ||
| Paricalcitol attenuates renal interstitial fibrosis in obstructive nephropathy | Q79326178 | ||
| Difference in the expression of hormone receptors and fibrotic markers in the human peritoneum--implications for therapeutic targets to prevent encapsulating peritoneal sclerosis | Q83758260 | ||
| P433 | issue | 2 | |
| P921 | main subject | sclerosing encapsulating peritonitis | Q26805194 |
| P304 | page(s) | 132-142 | |
| P577 | publication date | 2012-10-02 | |
| P1433 | published in | Peritoneal Dialysis International | Q15758672 |
| P1476 | title | 22-Oxacalcitriol prevents progression of peritoneal fibrosis in a mouse model | |
| P478 | volume | 33 |
| Q42679595 | 1,25(OH)2D3 treatment attenuates high glucose‑induced peritoneal epithelial to mesenchymal transition in mice |
| Q92482977 | 1,25-Dihydroxyvitamin D3 Prevents Epithelial-Mesenchymal Transition of HMrSV5 Human Peritoneal Mesothelial Cells by Inhibiting Histone Deacetylase 3 (HDAC3) and Increasing Vitamin D Receptor (VDR) Expression Through the Wnt/β-Catenin Signaling Pathw |
| Q36589381 | 20S-hydroxyvitamin D3, noncalcemic product of CYP11A1 action on vitamin D3, exhibits potent antifibrogenic activity in vivo |
| Q38271501 | A review of rodent models of peritoneal dialysis and its complications |
| Q40790185 | Chondroitin sulfate prevents peritoneal fibrosis in mice by suppressing NF-κB activation |
| Q38228157 | Effects of vitamin D on parathyroid hormone and clinical outcomes in peritoneal dialysis: a narrative review. |
| Q91973321 | Expression of XBP1s in peritoneal mesothelial cells is critical for inflammation-induced peritoneal fibrosis |
| Q42002311 | New insights into therapeutic strategies for the treatment of peritoneal fibrosis: learning from histochemical analyses of animal models |
| Q38568149 | Preserving the peritoneal membrane in long-term peritoneal dialysis patients |
| Q41083786 | SAHA Suppresses Peritoneal Fibrosis in Mice |
| Q91866158 | The Clinical Implication of Vitamin D Nanomedicine for Peritoneal Dialysis-Related Peritoneal Damage |
| Q54343838 | Vitamin D and S-farnesylthiosalicylic acid have a synergistic effect on hepatic stellate cells proliferation. |
| Q26765878 | Vitamin D and the Epithelial to Mesenchymal Transition |
| Q36162579 | Vitamin D can ameliorate chlorhexidine gluconate-induced peritoneal fibrosis and functional deterioration through the inhibition of epithelial-to-mesenchymal transition of mesothelial cells |
Search more.